Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.380
0.00 (0.00%)
May 18, 2026, 4:00 PM EDT - Market closed
CNTB Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, CNTB stock has a consensus rating of "Strong Buy" and an average price target of $7.90. The average 1-year stock price forecast is 231.93% higher than the current stock price, while the lowest is $6.00 (+152.10%) and the highest is $10 (+320.17%).
Price Target: $7.90 (+231.93%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 1, 2026.
Analyst Ratings
The average analyst rating for CNTB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +320.17% | Apr 1, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +320.17% | Mar 31, 2026 |
| Lake Street | Lake Street | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +278.15% | Dec 1, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +320.17% | Nov 13, 2025 |
| BTIG | BTIG | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +320.17% | Oct 31, 2025 |
Financial Forecast
Revenue This Year
5.56M
from 64.00K
Increased by 8,590.63%
Revenue Next Year
77.54M
from 5.56M
Increased by 1,294.14%
EPS This Year
-4.18
from -1.00
EPS Next Year
-4.34
from -4.18
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 15.8M | 301.2M | ||||||
| Avg | 5.6M | 77.5M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 24,509.4% | 5,314.8% | ||||||
| Avg | 8,590.6% | 1,294.1% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.79 | -1.14 | |
| Avg | -4.18 | -4.34 | |
| Low | -7.45 | -8.52 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.